Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis
IntroductionRoxadustat treatment in PD patients is equivalent to ESAs in increasing hemoglobin (Hb). But blood pressure, cardiovascular parameters, cardio-cerebrovascular complications and prognosis in the two groups before and after treatment has not been sufficiently discussed.MethodsSixty PD pati...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2023-06-01
|
| Series: | Frontiers in Medicine |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1166024/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|